When does your fast activate ketosis and autophagy?

What happens hour by hour?

During the first 3–4 hours after a meal, your body digests food and burns blood glucose while insulin is high. Then, roughly from hour 4 to hour 12, insulin falls and the body draws on glycogen stores in the liver. As these run down, usually after 12–16 hours, the body begins ketosis - burning fat and producing ketones. Autophagy gradually increases during this process.

What is autophagy?

Autophagy is the process by which cells break down and recycle damaged proteins and components. This natural housekeeping intensifies when food energy is unavailable. The literature often discusses an increase after 16–18 hours of fasting, but most precise timing data comes from animal studies, and exact thresholds in humans remain uncertain.

Why does meal size matter?

The larger and later the final meal, the longer digestion and glycogen depletion take, delaying ketosis and autophagy. A light evening snack leads to a fasting state sooner than a heavy, fatty dinner. The calculator therefore adjusts phase timing for your final meal's size.

Which fasting schedule should you choose?

The most popular is 16:8 (16 hours fasting, an 8-hour eating window), which is relatively easy to maintain. More advanced options are 18:6 and 20:4, while OMAD means one meal a day. No single schedule is best - consistency and sustainability matter. Fasts of 36–168 hours (up to 7 days) are a separate category requiring deliberate preparation and medical supervision. Compare their modelled phases in the calculator.

Not automatically after 12 hours. It depends on what and when you last eat. A large dinner at 21:00 shifts modelled ketosis and autophagy later; a light meal at 18:00 shortens the path.

The calculator estimates phases from your actual last meal: enter the time and a schedule (16:8, 18:6, 20:4, OMAD or multi-day fasting). The timeline shows modelled digestion, ketosis, autophagy and when the eating window opens. Free to use, in Polish local time.

In this area, evidence comes mainly from preclinical studies (animal models and cell cultures); large randomised human trials are lacking. Here is what is known and what remains a hypothesis:

What research suggests

Egg maturation: in mouse models, autophagy is necessary for oocyte and early embryo development; disabling autophagy genes such as Atg5 or Beclin1 disrupts development. Spermatogenesis: autophagy participates in sperm formation and maintenance of motility. Ovarian ageing: one hypothesis is that more effective autophagy delays ovarian reserve decline by removing damaged mitochondria and reducing oxidative stress.

Hypotheses, not recommendations

Moderate intermittent fasting may improve metabolic measures such as insulin sensitivity and weight, indirectly supporting fertility, especially with PCOS. This is an indirect inference, not a fertility benefit established by randomised trials.

The other side: risk

Overly restrictive fasting or energy deficiency in women can disrupt the hypothalamic–pituitary–ovarian axis (functional hypothalamic amenorrhoea), reducing rather than improving fertility. Warning signs include missed periods, chronic fatigue and hair loss. Prolonged fasting is not recommended during pregnancy, breastfeeding or while trying to conceive.

This is a research overview, not clinical advice. Discuss fertility decisions with a doctor.

The female hormonal system is more sensitive to energy deficiency than the male system: the hypothalamic–pituitary–ovarian axis, including kisspeptin neurons regulating GnRH release, can interpret prolonged fasting as scarcity and reduce sex hormone activity. This underlies the general observation that women often tolerate gentler schedules better (12–14 hours) than aggressive daily fasting.

Cycle phases and fasting duration

Follicular phase (days 1–13, from menstruation to ovulation): rising oestrogen improves insulin sensitivity and fasting tolerance; this is generally the easier phase for longer windows such as 16:8 or occasional 24-hour fasts.
Ovulation (around day 14): tolerance may remain good, but the hormonal axis is particularly sensitive to energy stress.
Luteal phase, especially the final week before menstruation: progesterone increases energy needs by about 100–300 kcal/day, while insulin resistance and appetite rise. Stress from prolonged fasting can more easily disrupt the cycle, so many protocols suggest shortening fasting to 12–13 hours or taking a break.

What research says

Direct randomised trials comparing fasting and menstrual cycles are limited. Ramadan studies report temporary menstrual irregularitiesin some women, resolving afterwards. Time-restricted eating studies in women with PCOS suggest improvements in insulin sensitivity and androgen levels with moderate windows. Conversely, chronic energy deficiency is an established pathway to functional hypothalamic amenorrhoea (FHA), especially in lean, physically active women.

Practical principles

Start with 12 hours and extend gradually; monitor cycle length, flow and PMS. Changes can signal that fasting is too long. Fasts of 36+ hours are better timed in the follicular phaserather than just before menstruation. Do not combine prolonged fasting with strenuous exercise and a large calorie deficit. Extended fasting is contraindicated during pregnancy, breastfeeding, attempts to conceive, FHA or eating disorders.

This educational section does not replace medical or dietetic advice. If your cycle becomes irregular, consult a professional.

In cancer, autophagy is a double-edged sword - as described in the scientific literature:

The protective side

In healthy tissue, autophagy can suppress tumour formation by removing damaged mitochondria and proteins, limiting oxidative stress and chronic inflammation that contribute to mutations.

The risky side

In an established tumour cancer cells can use autophagy to survive starvation and treatment stress - one mechanism of chemotherapy resistance. Clinical trials therefore also investigate autophagy inhibitors such as hydroxychloroquine alongside treatment.

Fasting and chemotherapy: what trials investigate

Fasting-mimicking diets during chemotherapy have been studied in early clinical trials. Some signals suggest improved treatment tolerance and healthy-cell protection, but trials are small and findings mixed. Fasting during cancer treatment carries real risks: malnutrition, muscle loss, cachexia and weakened immunity.